Built to watch global equities from every angle.
Spider Eyes Research was founded on a simple premise: the firms that find the best opportunities are rarely the fastest — they are the ones that keep looking after everyone else has moved on.
The book holds one position in each of 15 companies, across the United States, Europe and the United Kingdom. Research is produced in-house, and every note is a position the firm would be willing to defend rather than a recommendation softened for consensus.
- 2026
- Founded
- 15
- Equity positions held
- 7
- Notes published
- 5
- Companies written up
Published research is a subset: 5 of the 15 companies held have been written up here, all of them US listings so far. Subscribers see the rest, and notes reach them first.
How the firm works: the spider's four eyes
Arguing both cases
A thesis is only worth holding if it can be shown to be wrong. Every note published here argues both sides: what supports the position, and what would break it — key risks, uncertainties, what could go wrong, what is worth watching next. Each states the conditions the argument depends on, so a reader can check later whether they held.
That is why the notes are written as positions rather than recommendations. A recommendation asks to be believed; a position states what it is resting on and can be measured against it.
What counts as an opportunity
An opportunity is a gap between what the market has priced and what the evidence supports. Finding one is the work; sizing it is what makes it a position. Every note puts a number against it — a discounted cash flow, an implied value, a range where the honest answer is a range — and says what the market is currently paying instead.
Gaps usually open for a reason that will not last. A year of heavy capital spending that depresses earnings while it builds the next decade's capacity. A macro shock that moves a share price further than it moves the business. A single quarter read as a trend. The work is to tell those apart from the ones that will last, which means projecting the company forward rather than marking it to the last print.
That is where patience earns its place. A company is followed through those moments rather than met at them — quarter by quarter, filing by filing — because a condition is only recognisable as temporary if you were watching before it arrived. The notes here are that pattern: a multiple falling while results improve, a recovery priced in while the re-rating behind it is not, capacity being built and written down at the same time.
Working with the firm
The research is published by subscription to a small readership. Subscribers see coverage this site does not — 15 companies are held against 5 written up here — and they see it first. A subscription is access to the publication, not the engagement of an adviser: everyone receives the same notes, and the firm takes no view on anyone's own position.
The firm holds no client capital and plays no advisory role. Its regulatory status is set out in full.